Offer - Urjas Oil for just ₹ 1 X
Cor NVP Tablet is an allopathic medicine The correct dosage of Cor NVP Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Cor NVP Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Cor NVP Tablet safe for pregnant women?
Pregnant women may get mild side effects from Cor NVP Tablet.
Is the use of Cor NVP Tablet safe during breastfeeding?
Cor NVP Tablet may have very limited harmful effects for breastfeeding women.
What is the effect of Cor NVP Tablet on the Kidneys?
Cor NVP Tablet is not harmful for kidneys.
What is the effect of Cor NVP Tablet on the Liver?
Cor NVP Tablet does not damage the liver.
What is the effect of Cor NVP Tablet on the Heart?
Using Cor NVP Tablet does not have any harmful effects on the heart.
Cor NVP Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Cor NVP Tablet unless your doctor advises you to do so -
Is this Cor NVP Tablet habit forming or addictive?
Cor NVP Tablet does not cause addiction.
Interaction between Food and Cor NVP Tablet
Taking Cor NVP Tablet with food does not harm your health.
Interaction between Alcohol and Cor NVP Tablet
It is difficult to say anything about the effect of Cor NVP Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 469
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclegis (doxylamine succinate and pyridoxine hydrochloride)